跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
米氮平片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mirtazapine Tablets
Approved
化学药品
Mirtazapine Tablets
Sandoz Gmbh
🇨🇳 National Medical Products Administration
Approval Date
Jul 29, 2022
Approval ID
8Iee0Q8gTK5
Company
Sandoz Gmbh
Type
化学药品
Approval Details
Approval Id
8Iee0Q8gTK5
Approval Number
国药准字HJ20181173
Generic Name
米氮平片
Generic Name En
Mirtazapine Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
30mg
Reg Date
2022-07-29
Expired Date
2027-07-28
Company Name
Sandoz Gmbh
Company Address
Biochemiestraße 10, 6250 Kundl, Austria
Production Company Name
NOVARTIS (BANGLADESH) LIMITED
Production Company Address
Squibb Road, Cherag Ali Market Tongi Industrial Area, Gazipur-1711, Bangladesh
Company Detail Path
/organization/sandoz-gmbh
Production Company Detail Path
/organization/novartis-bangladesh-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 29, 2022
Approval ID
8Iee0Q8gTK5
Type
化学药品
Back to NMPA Approvals